Title: An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic A42 aggregates linked with Alzheimer's disease.
Authors: Habchi J, Arosio P, Perni M, Costa AR, Yagi-Utsumi M, Joshi P, Chia S, Cohen SI, Muller MB, Linse S, Nollen EA, Dobson CM, Knowles TP, Vendruscolo M
Journal: Sci Adv
Published: 2016-02
Volume: 2
Pages: e1501244